[ad_1] Advisory Committee Voted 10 to 6 in Favor, Concluding that Elamipretide is Effective for the Treatment of Barth Syndrome Elamipretide NDA Received Priority Review with a PDUFA Action Date of January 29, 2025 If Approved, Elamipretide […]
Tag: Biotechnology
UCB showcases new data for gMG management at the 2024 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session
[ad_1] UCB will contribute 14 presentations, including an oral presentation, selected to feature across the AANEM and MGFA meeting, emphasizing UCB’s leadership in neuromuscular research Presentations showcase new data for UCB’s gMG treatments, including post hoc […]
Kvantify launches physics-based binding affinity-software for drug discovery with high accuracy and unprecedented speed
[ad_1] Koffee binding affinity is the latest addition to Kvantify’s computational drug discovery platform, helping the pharmaceutical and biotech industries design new drugs with an unmatched combination of speed and precision. COPENHAGEN, Denmark, Oct. 11, […]
The Galien Foundation Hosts 2024 Galien Week of Innovation to Celebrate the Latest Research and Clinical Pathways Toward Diagnoses, Treatments, and Cures
[ad_1] Week Begins with In-Depth Discussions on Life Science Trends and Celebrates Innovative Products that Have Made a Significant Impact on Patient Care Galien Forum and Awards Ceremony to Take Place on November 7 in […]
RIVERMARK MEDICAL CLOSES $30 MILLION SERIES C FINANCING TO ADVANCE DEVELOPMENT OF FLOSTENT™ SYSTEM FOR BENIGN PROSTATIC HYPERPLASIA
[ad_1] Novel technology aims to provide immediate relief for patients while seamlessly integrating into routine urological visits MILWAUKEE, Oct. 10, 2024 /PRNewswire/ — Rivermark Medical, a leader in minimally invasive solutions for Benign Prostatic Hyperplasia (BPH), […]
